Investor Centre


Cann is the first Australian company to secure the necessary licences to undertake research and to cultivate cannabis for human medicinal and research purposes under the Australian Government’s new medicinal cannabis regulatory system. Cann is building an Australian based business intended to take advantage of opportunities relating to the emerging medicinal cannabis industry.

Cann has established facilities and systems which can cultivate medicinal cannabis in accordance with the requirements under the Narcotic Drugs Act 1967 (ND Act). In due course, Cann intends to extend its operational activities to the manufacturing of medicinal cannabis products.

Cann’s vision is to be a leading developer and supplier of cannabis, cannabis resin and medicinal cannabis products into the Australian market, and to supply overseas markets as those opportunities become available.

Our share register is maintained by Link Market Services Limited. Shareholders can view and update holding details, including Tax File Number or ABN, contact details and communications preferences, by visiting the share registry website in new window

ASX Announcements

More Announcements


Download Prospectus